Biochemistry and molecular biology

New technologies and molecular discoveries are changing the way diagnoses are made. But how will already burdened molecular pathology labs cope with more cases and restricted budgets?

Why we need to harmonize fasting definitions for blood sampling

Gene expression panel could help breast cancer patients with a low risk of recurrence avoid unnecessary chemotherapy

Keith Miller is Director and co-founder of CADQAS (Cancer Diagnostic Quality Assurance Services), a not-for-profit community interest company hosted by Poundbury Cancer Institute (PCI).

Christopher Hudson is Director of Tissue Diagnostics UK and Ireland at Roche, the multinational life sciences company that supports the Poundbury Cancer Institute through funding and research collaboration.

A new device, the Cytosponge, could pair with biomarker testing to offer an effective, low-cost way to diagnose and stratify Barrett’s esophagus

Tumor-activated DNA minicircles offer a potential solution for cancer detection, treatment, or both.

Glycated serum protein testing could expand diagnostic and treatment options.

Molecular diagnostics provide us with huge amounts of data – but, as a profession, we’re still working on the best ways of collecting and using it

Poundbury Cancer Institute aims to put pathology at the forefront of cancer research, and bring industry, national healthcare service and quality assurance together to expand the use of companion diagnostics and important biological markers.